MIDDLETON, Wis., July 22, 2025 /PRNewswire/ -- Natus Medical Incorporated is continuing its commitment to innovation and expanding the functionality of one of its flagship products with the ...
MIDDLETON, Wis., Dec. 4, 2024 /PRNewswire/ -- Natus Medical Incorporated will debut its highly anticipated, FDA-cleared point-of-care EEG solution, BrainWatch™, during the American Epilepsy Society ...
MIDDLETON, Wis., Dec. 3, 2025 /PRNewswire/ -- Natus Medical Incorporated announced the electrographic status epilepticus diagnosis capability of its BrainWatch point-of-care EEG solution, featuring ...
MIDDLETON, Wis., Oct. 10, 2024 /PRNewswire/ -- Natus Medical Incorporated announced it has submitted an FDA 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its Natus ...
MIDDLETON, Wis., May 20, 2025 /PRNewswire/ -- Natus Medical Incorporated has announced the official launch of BrainWatch™, the highly anticipated point-of-care EEG solution designed to bring the ...
Natus Medical Incorporated, a global healthcare provider to screen, diagnose, and treat disorders affecting the brain and neural pathways, has announced the electrographic status epilepticus diagnosis ...
MIDDLETON, Wis., Aug. 7, 2024 /PRNewswire/ -- Natus Medical Incorporated has announced the launch of autoSCORE, the first-of-its-kind artificial intelligence model capable of automatic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results